We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers.
- Authors
Bakker, Daphne S.; Ariens, Lieneke F. M.; Giovannone, Barbara; Hijnen, DirkJan; Delemarre, Eveline M.; Knol, Edward; Nierkens, Stefan; Bruin‐Weller, Marjolein S.; Thijs, Judith L.; Drylewicz, Julia
- Abstract
EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers Keywords: atopic dermatitis; biologics; biomarkers EN atopic dermatitis biologics biomarkers 3287 3289 3 12/03/20 20201201 NES 201201 During the past decade, new more targeted therapies for the treatment of atopic dermatitis (AD) have been developed and are currently under investigation in clinical trials. As few patients did show a quick drop in sIL-2R, extending the current model to a larger patient population including different phenotypes of AD might identify subtypes of AD patients in whom sIL-2R is an important marker.
- Subjects
ATOPIC dermatitis; BIOMARKERS; SERUM
- Publication
Allergy, 2020, Vol 75, Issue 12, p3287
- ISSN
0105-4538
- Publication type
Article
- DOI
10.1111/all.14492